. 2023 Jul 14;38(1):2235095. doi: 10.1080/14756366.2023.2235095

Table 4.

Application in modification of natural products for antidiabetic activity.

Parent compound	Derivative	Target	Pharmacological activity(EC₅₀)	Reference
Oroxylin A	67	rat intestinal α-glucosidase	35.43 µM	⁸⁷
Oroxylin A	67	Yeast α-glucosidase	98.84 µM
Flavonone	68	α-glucosidase	23.4 µM	⁸⁸
Flavonone	69	α-glucosidase	4.1 µM	⁸⁸